Australia’s Medigrowth Partners with Victorian Universities on Pediatric Trials
-
Australia’s Medigrowth Partners with Victorian Universities on Pediatric Trials
In a significant step for pediatric medical cannabis research, Australian biotech company Medigrowth has partnered with Deakin, Swinburne, and Monash universities to investigate cannabis-based treatments for anxiety and autism in children aged five to twelve. These collaborative clinical trials are part of a broader push to explore safe, effective, and regulated options for managing complex…
-
Brazil’s Embrapa Launches 12-Year Cannabis Research Program
In a landmark move for Brazil’s agricultural and scientific sectors, the country’s leading agricultural research agency, Embrapa, has announced a 12-year national research program dedicated to cannabis. The initiative will focus on cultivation techniques, seed banking, and region-specific production methods, with applications spanning medical, food, and industrial uses. This long-term commitment reflects a growing recognition…
